Across TCGA pan-cancer cohorts, CXorf51A RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated CXorf51A data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher CXorf51A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CXorf51A expression acts as an unfavorable survival marker.
THCA, BLCA, and STAD are the cancer types where CXorf51A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.